Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
26.7M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
1.16M
-
Shares change
-
+1.16M
-
Total reported value, excl. options
-
$1.38M
-
Value change
-
+$1.38M
-
Number of buys
-
16
-
Price
-
$1.42
Significant Holders of Lunai Bioworks Inc. - Common Stock, par value $0.0001 per share (LNAI) as of Q3 2025
19 filings reported holding LNAI - Lunai Bioworks Inc. - Common Stock, par value $0.0001 per share as of Q3 2025.
Lunai Bioworks Inc. - Common Stock, par value $0.0001 per share (LNAI) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.16M shares
of 26.7M outstanding shares and own 4.35% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (518K shares), MILLENNIUM MANAGEMENT LLC (203K shares), BlackRock, Inc. (127K shares), GEODE CAPITAL MANAGEMENT, LLC (127K shares), RENAISSANCE TECHNOLOGIES LLC (37.8K shares), UBS Group AG (37.4K shares), STATE STREET CORP (35.7K shares), NORTHERN TRUST CORP (21.4K shares), TWO SIGMA INVESTMENTS, LP (16.4K shares), and GOLDMAN SACHS GROUP INC (14.4K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.